In addition, HHS Secretary Robert F. Kennedy Jr. addressed the delay in Novavax's approval in a CBS interview earlier this ...

The UK’s Voluntary Scheme for Branded Medicines Pricing and Access ( VPAG) was agreed upon by the ABPI, the research-based ...

AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the ...

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

Valneva said it has been supplying Ixchiq to help the French government respond to a major outbreak of chikungunya in La ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

Anyone who purports to care about global health, about public health, should be speaking out against these actions, loudly ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...

Despite being on the US market since 1989 – initially for medical uses like strabismus and blepharospasm, and later for ...